- Login
- Register & Subscribe
- Language: EN FR DE
Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.
The latest MedNous journal. Subscribe to download.
Free Featured Article
Friday 5 February 2010
Country: Austria
As those who attend medical conferences know well, biotech executives like to talk about what they do in terms of models.
“The one-product model is dead, you have to have a platform,” one conference attendee will say while his colleague will reply, “My model is to both provide research services and to develop a proprietary drug pipeline.”
Implicit in the talk of dual strategies is the idea that it is no longer possible to simply patent the results of a single piece of research, find business angels to back it and develop the product to the proof-of-concept stage where it then becomes eligible for out-licensing. Yet, this very straightforward model can still be made to work.
A case in point is a deal announced on 3 February 2010 by the Austria
Thursday 4 February 2010
Country: United Kingdom
Friday 29 January 2010
Country: United Kingdom
Visit our news section for more articles.
MedNous is a print publication and a website for medical entrepreneurs in Europe. The name is derived from the Greek word for knowledge – nous – and the English word, medical.
Monday February 8 2010
Friday February 5 2010
Friday February 5 2010
Friday February 5 2010
Thursday February 4 2010